Intelligence Search Intelligence Filter by: Industry Team Airport & AviationAutomotiveEmerging TechnologiesEnergy Food & BeverageHealth CareHospitality, Resort & GolfInsurance & Reinsurance Life SciencesManufacturingMedical DevicesSports Practice Area Business Law All Business LawEmployee Benefits & Executive CompensationEnvironmental RegulationEstates & TrustsFinance & Financial InstitutionsHealth Care Finance Private Equity & Venture CapitalPublic FinanceReal EstateSecurities, Commodities & Exchange RegulationTaxationTransactional & Securities Government & Public Policy All Government & Public PolicyFDA RegulatoryFederal & State Energy RegulatoryFreight & Commuter RailGovernment Procurement Immigration, Nationality & Consular LawNHTSA & Motor Vehicle SafetyPolitical LawPublic Policy Intellectual Property All Intellectual PropertyBusiness Method & Software PatentsChemical, Biotechnology & PharmaceuticalElectronicsGreen Energy TechnologiesInformation Technology & Outsourcing IP Due DiligenceIP LitigationMechanical & Electromechanical TechnologiesPatent Office TrialsTrademark, Copyright & Advertising Counseling International All InternationalChina EuropeJapan Litigation All LitigationAntitrustAppellateBankruptcy & Business ReorganizationsBusiness Litigation & Dispute ResolutionConstructionConsumer Financial Services Distribution & FranchiseGovernment Enforcement, Compliance & White Collar DefenseInsurance & Reinsurance LitigationLabor & EmploymentPrivacy, Security & Information ManagementSecurities Enforcement & LitigationTrade Secret Noncompete Litigation Topic Accountable Care OrganizationsAmerica Invents Act (Patent Reform)Consumer Protection Act Corporate GovernanceDodd–Frank Wall Street ReformExport Control/Economic Sanctions Foreign Corrupt Practices Act (FCPA)Health Care ReformPersonalized Medicine Type ArticleBlog Post BookNewsletter VideoWhite Paper Featured All Filters applied: Search phrase entered: Sort results by: Most Recent Most Viewed Most Shared Foley Blogs: CFSL Bulletin Cleantech & Nano Dashboard Insights Labor & Employment Law Perspectives Personalized Medicine Bulletin PharmaPatents Renewable Energy Outlook Wisconsin Appellate Law 12345next Medical Device Industry Responds to FDA's Overseas Clinical Trial Proposed Rule 16 June 2013 Personalized Medicine Bulletin Guest Post By Jennifer M. Forde, Nathan A. Beaver and David L. Rosen In a resounding manner, members of the medical device industry recently filed comments reacting... Maximizing the Value of Pre-AIA Patent Applications Using First-to-File Regime – Part I 15 June 2013 Cleantech & Nano Authored by Emily Liu* and Tianran Yan The first-to-file provisions of the Leahy-Smith America Invents Act (AIA) took effect on March 16, 2013. The predominant... FDA's Plan to Regulate LDTs 14 June 2013 Personalized Medicine Bulletin Guest Post By David L. Rosen and Nathan A. Beaver In a remarkable move, the Food and Drug Administration recently indicated that it plans to take new steps to... U.S. Patent Office Issues Guidance to Examiners on Supreme Court's Myriad Decision 14 June 2013 Cleantech & Nano Today the USPTO issued guidance (PTO_Myriad_Guidelines) to Examiners on how to apply the Myriad Supreme Court decision to applications under examination. The... Isolated DNA Is Not Patent-Eligible 13 June 2013 Personalized Medicine Bulletin Today the U.S. Supreme Court in Ass’n for Molecular Pathology v. Myriad Genetics, Inc., __ U.S. __ (2013) (opinion here), held that genes and DNA fragments merely... Monsanto Averts Declaratory Judgment Suit 13 June 2013 Personalized Medicine Bulletin On June 10, 2013, the U.S. Court of Appeals for the Federal Circuit held that Monsanto’s representation that it would not pursue farmers and seed sellers for... Supreme Court Decides Myriad Case: Synthetic DNA Held Patentable & Implications for Nanotech 13 June 2013 Cleantech & Nano Today the Supreme Court rendered its decision in the landmark Myriad case, holding that naturally occurring DNA segments are not patentable, but synthetic DNA... Supreme Court Decides Myriad Gene Patents Case, Holds Isolated Human Genes May Not Be Patented 13 June 2013 PharmaPatents On June 13, 2013, the Supreme Court issued its long-awaited decision in the “ACLU/Myriad” gene patents case (Association For Molecular Pathology v. Myriad Genetics,... U.S. Patent "Micro-Entity" Rules & Other Cost Savings Strategies: Do You qualify for 75% Off Your U.S. Patent Filing Costs? 12 June 2013 Cleantech & Nano The short answer is that a company or individual who already is qualified as a small entity (which entitles you to 50% off U.S. patent filing... Foley & Lardner LLP Launches Legal Innovation Hub for NextGen Manufacturers 10 June 2013 Cleantech & Nano Our firm recently launched its Legal Innovation HubSM for NextGen Manufacturers, a major firm-wide initiative to provide access to customized service for... 12345next Related 1 2 3
Medical Device Industry Responds to FDA's Overseas Clinical Trial Proposed Rule 16 June 2013 Personalized Medicine Bulletin Guest Post By Jennifer M. Forde, Nathan A. Beaver and David L. Rosen In a resounding manner, members of the medical device industry recently filed comments reacting...
Maximizing the Value of Pre-AIA Patent Applications Using First-to-File Regime – Part I 15 June 2013 Cleantech & Nano Authored by Emily Liu* and Tianran Yan The first-to-file provisions of the Leahy-Smith America Invents Act (AIA) took effect on March 16, 2013. The predominant...
FDA's Plan to Regulate LDTs 14 June 2013 Personalized Medicine Bulletin Guest Post By David L. Rosen and Nathan A. Beaver In a remarkable move, the Food and Drug Administration recently indicated that it plans to take new steps to...
U.S. Patent Office Issues Guidance to Examiners on Supreme Court's Myriad Decision 14 June 2013 Cleantech & Nano Today the USPTO issued guidance (PTO_Myriad_Guidelines) to Examiners on how to apply the Myriad Supreme Court decision to applications under examination. The...
Isolated DNA Is Not Patent-Eligible 13 June 2013 Personalized Medicine Bulletin Today the U.S. Supreme Court in Ass’n for Molecular Pathology v. Myriad Genetics, Inc., __ U.S. __ (2013) (opinion here), held that genes and DNA fragments merely...
Monsanto Averts Declaratory Judgment Suit 13 June 2013 Personalized Medicine Bulletin On June 10, 2013, the U.S. Court of Appeals for the Federal Circuit held that Monsanto’s representation that it would not pursue farmers and seed sellers for...
Supreme Court Decides Myriad Case: Synthetic DNA Held Patentable & Implications for Nanotech 13 June 2013 Cleantech & Nano Today the Supreme Court rendered its decision in the landmark Myriad case, holding that naturally occurring DNA segments are not patentable, but synthetic DNA...
Supreme Court Decides Myriad Gene Patents Case, Holds Isolated Human Genes May Not Be Patented 13 June 2013 PharmaPatents On June 13, 2013, the Supreme Court issued its long-awaited decision in the “ACLU/Myriad” gene patents case (Association For Molecular Pathology v. Myriad Genetics,...
U.S. Patent "Micro-Entity" Rules & Other Cost Savings Strategies: Do You qualify for 75% Off Your U.S. Patent Filing Costs? 12 June 2013 Cleantech & Nano The short answer is that a company or individual who already is qualified as a small entity (which entitles you to 50% off U.S. patent filing...
Foley & Lardner LLP Launches Legal Innovation Hub for NextGen Manufacturers 10 June 2013 Cleantech & Nano Our firm recently launched its Legal Innovation HubSM for NextGen Manufacturers, a major firm-wide initiative to provide access to customized service for...